
|Articles|April 25, 2016
Perrigo Confirms Papa Exit
April 25, 2016.
Advertisement
Following their refusal to comment Friday on "rumors" that CEO Joseph Papa was leaving to head Valeant Pharmaceuticals, Dublin-based Perrigo has today confirmed the rumor's truth in announcing the appointment of John T. Hendrickson as Perrigo's Chief Executive Officer, "effective immediately, following the resignation and departure of Joseph C. Papa".
Hendrickson has served as President of Perrigo since October 2015. He was formerly Executive Vice President, Global Operations & Supply Chain between 2006 and 2015. Meanwhile, Valeant announced today that Papa tis expected to join the company as Chairman and CEO by early May.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Artisan Partners’ Director Calls for Novartis Board Shake-Up
2
The Agentic AI Revolution in Biopharma
3
340B Under Pressure: Inside Pharma's Push for Greater Clarity
4
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
5




